ReviewFrontiers in immunology2026
HBV reactivation during immunotherapy for hepatocellular carcinoma: risk factors and clinical management.
Yurou Jin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it